SCYNEXIS, Inc. (NasdaqCM: SCYX)
Health Care · Pharmaceuticals · US
$4.08
0.00% today · -33.8% 1Y
SCYNEXIS, Inc. (NasdaqCM: SCYX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $40.59M and employs 18 people.
Over the last twelve months the share price has lost 33.8%, trading between 3.53 and 9.12.
Tweenvest scores SCYNEXIS, Inc. across four factors: quality 46/100, value 54/100. Its strongest factor is value.
SCYX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $40.59M
- Revenue (TTM)
- $19.22M
- P/E
- —
- EPS
- -1.33
- Dividend yield
- —
- Beta (5Y)
- 1.06
- 52-week high
- $9.12
- 52-week low
- $3.53
- Avg volume (3M)
- —
- Shares outstanding
- 9.95M
- Employees
- 18
- Next earnings
- —
About SCYNEXIS, Inc.
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
- ISIN
- US8112923094
- Founded
- 1999
- Listed since
- May 2, 2014
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Orion Infusion LimitedDSE: ORIONINFU | $41.46M | Tk250.80 | -2.68% |
| Enzymatica AB (publ)OM: ENZY | $41.39M | Skr1.77 | +3.81% |
| Nasus Pharma Ltd.NYSEAM: NSRX | $41.12M | $3.43 | -2.28% |
| Hwail Pharmaceutical Co.,Ltd.KOSDAQ: A061250 | $40.68M | ₩6,500.00 | +2.36% |
| Herantis Pharma OyjHLSE: HRTIS | $39.83M | €1.34 | -5.36% |
| BF Biosciences LimitedKASE: BFBIO | $39.61M | PKRs124.18 | -0.40% |
| Filana Therapeutics, Inc.NasdaqCM: FLNA | $39.46M | $0.77 | -5.94% |
| Incannex Healthcare Inc.NasdaqCM: IXHL | $38.89M | $2.93 | -5.48% |
Figures last refreshed Oct 11, 2026.